bromocriptine has been researched along with Carcinoma, Hepatocellular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, B; Chen, XP; Ding, L; Li, CL; Wang, ZH; Zhang, WG; Zhang, ZW | 1 |
Cao, B; Chen, XP; Ding, L; Jing, K; Li, J; Zhang, DY; Zhang, ZW; Zhu, P | 1 |
2 other study(ies) available for bromocriptine and Carcinoma, Hepatocellular
Article | Year |
---|---|
[Study on the mechanism of reversing multidrug resistance of hepatocarcinoma by bromocriptine].
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bromocriptine; Carcinoma, Hepatocellular; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; RNA, Messenger; Tumor Cells, Cultured | 2006 |
[Study on sensitivity to chemotherapy by combination therapy with tumor necrosis factor-alpha and bromocriptine in the multidrug resistant subcell line of HepG2].
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Bromocriptine; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Necrosis Factor-alpha | 2006 |